B2B Partnering Options

BioChannel Partners Ltd, established in 2003, is an international  B2B partnering and training company for suppliers of laboratory products.

Mission

Our mission is to support manufacturers and channel partners to find great partners and manage the relationship effectively.

Vision

We will be recognised by suppliers of laboratory products as the most efficient solution for developing channel partner networks.

Key People

Sharon Eaton

Managing Director: Sharon Eaton MBA

Sharon has worked in the Life Sciences industry (Amersham International, Roche/Boehringer Mannheim, Kodak Scientific Imaging Systems, Invitrogen) since 1987, gaining experience in R&D, regulatory compliance, sales, marketing and distributorship. She was an international channel partner manager in Europe, Eastern Europe, CIS and the Middle East. Products that she managed have ranged from commodity and cutting edge consumables, laboratory equipment, high tech instrumentation and software. Sharon founded BioChannel Partners Limited in 2003 to help busy distributor managers find candidates to introduce and manage sales of their products in new, international markets. A systematic process and a proprietary database containing profiles of over 25,000 firms has been developed which enables a client to quickly identify compatible, active distributors.

In 2013, along with Jonathan Cooper from george james Ltd, Sharon developed training courses to provide channel partner managers with a set of tools and processes to manage, inspire and lead their channel partners more efficiently and effective way.

Sharon has an MBA from Strathclyde University Business School.

Contact Sharon Eaton
Email: sharon@biochannelpartners.com
Tel: +44 1284 756 440
Mob: +44 789 008 7279
LinkedIn: https://www.linkedin.com/in/sharoneaton

Frank Craig

Chairman: Frank F. Craig PhD MBA

Dr Craig has over 20 years of international, general management experience gained from GlaxoSmithKline, Amersham Biosciences (as a Vice-President of R&D) and several start-up firms. He was responsible for managing product development of Green Fluorescent Protein (first identified by the 2008 Nobel Prize Winners for Chemistry) and many other products and services for the Life Sciences industry. Frank is a (co)-Founder of Aurora Biosciences (San Diego, USA), which had a peak market cap. of £1.6 billion. He was also a co-Founder and CEO of Smart Holograms (Cambridge, UK) – named as the UK’s Fastest Growing Company. Frank has raised £16 million in Venture Capital, £23 million via an IPO on NASDAQ and has delivered many commercial partnerships with global Life Sciences and Energy firms – resulting in recorded deal values of £180 million. He has been a Board Director of Smart Holograms and TekCel (Hopkinton, USA). Frank is currently the CEO of Sphere Fluidics, commercialising new lab-on-a-chip and picodroplet technology from Cambridge University.

He has a PhD in Cell Biology and Microbiology from Glasgow University and an MBA from Warwick Business School.

Contact Frank Craig
Email: frank@biochannelpartners.com
Mob:+44 7805 659566
LinkedIn:https://www.linkedin.com/in/frank-f-craig-6880717/